Review of Case Definitions for Myalgic Encephalomyelitis/Chronic Fatigue

Total Page:16

File Type:pdf, Size:1020Kb

Review of Case Definitions for Myalgic Encephalomyelitis/Chronic Fatigue Lim and Son J Transl Med (2020) 18:289 https://doi.org/10.1186/s12967-020-02455-0 Journal of Translational Medicine REVIEW Open Access Review of case defnitions for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) Eun‑Jin Lim and Chang‑Gue Son* Abstract Background: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating disease with unknown causes. From the perspectives on the etiology and pathophysiology, ME/CFS has been labeled diferently, which infu‑ enced changes in case defnitions and terminologies. This review sought to feature aspects of the history, develop‑ ments, and diferential symptoms in the case defnitions. Methods: A search was conducted through PubMed published to February 2020 using the following search key‑ words: case defnition AND chronic fatigue syndrome [MeSH Terms]. All reference lists of the included studies were checked. Of the included studies, the number of citations and the visibility in the literatures of the defnitions were considered for comparisons of the criteria. Results: Since the frst ’ME’ case defnition was developed in 1986, 25 case defnitions/diagnostic criteria were cre‑ ated based on three conceptual factors (etiology, pathophysiology, and exclusionary disorders). These factors can be categorized into four categories (ME, ME/CFS, CFS, and SEID) and broadly characterized according to primary disorder (ME‑viral, CFS‑unknown, ME/CFS‑infammatory, SEID‑multisystemic), compulsory symptoms (ME and ME/ CFS‑neuroinfammatory, CFS and SEID‑fatigue and/or malaise), and required conditions (ME‑infective agent, ME/ CFS, CFS, SEID‑symptoms associated with fatigue, e.g., duration of illness). ME and ME/CFS widely cover all symptom categories, while CFS mainly covers neurologic and neurocognitive symptoms. Fatigue, cognitive impairment, PEM, sleep disorder, and orthostatic intolerance were the overlapping symptoms of the 4 categories, which were included as SEID criteria. Conclusions: This study comprehensively described the journey of the development of case defnitions and com‑ pared the symptom criteria. This review provides broader insights and explanations to understand the complexity of ME/CFS for clinicians and researchers. Keywords: Myalgic encephalomyelitis, Chronic fatigue syndrome, Systemic exertion intolerance disease, Case defnition, Diagnostic criteria Background Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating disease with core symptoms of fatigue, unrefreshing sleep, postexertional malaise (PEM), *Correspondence: [email protected] and cognitive dysfunction for more than 6 months [1]. Institute of Bioscience and Integrative Medicine, Department of Korean Tis disorder afects individuals of all ages across all Medicine, Daejeon University, 62 Daehak‑ro, Dong‑gu, Daejeon, Republic socioeconomic, racial, and ethnic groups, ‘approximately of Korea estimated 1% of the population, 17 to 24 million people © The Author(s) 2020. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creat iveco mmons .org/licen ses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creat iveco mmons .org/publi cdoma in/ zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. Lim and Son J Transl Med (2020) 18:289 Page 2 of 10 worldwide [2, 3]. Te clinical impact of ME/CFS left 27% Terefore, this review aims to overview the develop- of the ME/CFS patients bedridden and 29% housebound, ment of ME/CFS case defnitions, which will provide leading to 50% unable to work full time and 21% una- physicians and researchers with a comprehensive picture ble to work at all [4]. In 2015, the Institute of Medicine of the current and prominent features of ME/CFS. (IOM) in the U.S. announced that ME/CFS is a serious health problem in the form of complex multisystem neu- Methods rological disorder, which should be the focus of national Literature search strategies and data collection medical and scientifc efort using the recommended To comprehensively collect the case defnitions of ME/ name ‘systemic exertion intolerance disorder (SEID)’ [5]. CFS, we performed a search through PubMed published Outbreaks of neurological paralysis-related symptoms to February 2020 and checked all reference lists of the with systemic malaise have occurred worldwide (e.g., included studies. Te following search keywords were Los Angeles in 1934 and Iceland 1947, followed by New used: case defnition AND chronic fatigue syndrome Zealand and Nevada), and ME/CFS was frst acknowl- [MeSH Terms]. We included studies only for adult popu- edged as a form of ’poliomyelitis’ and ’benign ME’ in the lations (> 18 years), and language was limited to English 1930s and 1950s [6–8]. Later, it was known to be sporadic (Additional fle 1. Figure S1). and not rare in the general population [9]. Te etiology Two authors independently read all the titles, abstracts, of the illness has yet to be revealed, which has led to no and full text retrieved by the search. Te literatures were established objective diagnostics, pathophysiology or viewed forward the background of case defnitions and therapeutics [4]. Accordingly, many expert groups have analyzed according to time-line based changes. Of those developed case defnitions based on clinical features. To included studies, comparisons of the criteria are limited date, over 20 ME/CFS case defnitions have been estab- to the eight defnitions (Ramsay, International Consen- lished by diferent groups in various countries [10]. Tese sus Criteria (ICC), Holmes, Australian, Oxford, Fukuda, defnitions refect the historical fow of the clinical fea- Canadian Consensus Criteria (CCC), systemic exertion tures and characteristics of the illness emphasized in a intolerance disease (SEID)) that were selected based on diferent way according to the perspectives of researchers the number of Google Scholar citations and the visibility [11]. in the literatures (Additional fle 1. Table S1). Recognition of the changes in the development of the case defnitions of ME/CFS is necessary for physicians Results and researchers to better understand the illness. Dif- Past and present of ME/CFS ferential diagnosis is crucial in the therapeutic process Since the frst recognition of ME/CFS in an outbreak to enhance treatment efcacy; however, a high number in Los Angeles 1934, the illness has undergone various of misdiagnoses can lead to delays in the diagnosis and changes in terminology and case defnition [17]. Dr. G. treatment of ME/CFS [12]. Approximately 37% of ME/ Beard (1839–1883) frst disclosed the illness in his book CFS-like patients had experienced alternative diagno- and introduced the term ’neurasthenia’ in the 1860 s [18]. ses, such as psychiatric, pain, or sleep disorders, in clin- Later, the features of neurologic symptoms during the ics [13]. Furthermore, the application of particular case U.K. outbreaks led to naming the illness ‘benign ME’ [19], defnitions profoundly impacts epidemiological stud- then Ramsay created the ’ME’ case defnition in 1986 ies of ME/CFS [14]. Te prevalence of ME/CFS could [20]. Serial outbreaks of the illness led to proposing that widely vary based on the application of case defnitions; the condition was linked to viral infection, which altered for example, there were fvefold diferences in prevalence its name to ‘chronic Epstein-Barr virus syndrome (EBVS)’ using the Fukuda (0.89%) and the Holmes defnition in 1982 [21] and ’postviral fatigue syndrome (PVFS)’ in (0.17%) [15]. 1985 [22]. In 1988, insufcient evidence in connection Numerous studies have also documented skepticism with the virus and numerous sporadic cases in the gen- among physicians about ME/CFS being a distinct clini- eral population led to the Centers for Disease Control cal entity, and they do not feel confdent in making the and Prevention (CDC) to create the new term ‘CFS’ (Hol- diagnosis [12, 16]. One of the reasons is a lack of under- mes defnition), which was proposed to more inclusively standing of ME/CFS, which is likely to result from the describe the symptom complex, including psychological complicated backgrounds of this disorder, including symptoms [23]. In 2003, the ’ME/CFS’ by CCC was pub- indefnite terminologies and etiology. In fact, ME/CFS lished embracing the clinical features of both ’ME’ and has been named diferently (e.g., postviral fatigue syn- ’CFS’ [24]. Te conception of ’ME’ or ’ME/CFS’ adopted drome, neurasthenia) depending on the perspectives of the notion of neuroinfammation [24, 25]. the researchers; likewise, diagnostic criteria or case def- Te terminologies of ME, CFS, and/or ME/CFS nitions have also been changed accordingly. have been and interchangeably used until present. Te Lim and Son J Transl Med (2020) 18:289 Page 3 of 10 complexity of those indefnite terminologies is shown ’neurosis’ that was indicative of psychiatric origin by in the international code for disease (ICD) system. Te Dr. S. Freud (1856–1939), who believed the illness was WHO initially classifed the illness as a neurological caused by unresolved conficts in the unconscious mind disorder in the ICD-8 (code 796.0) in 1969 [26]. Subse- [31]. Similarly, in the 1970s, McEvedy alleged its psy- quently, the ICD-10 (2016) classifed it as PVFS (code chological origin with the term ‘myalgia nervosa’ [32]. G93.3) indexing only ‘benign ME’ [27]—‘benign’ was Te debate on the origin of illness (psychological versus dropped in the 2019 version [28].
Recommended publications
  • Balo's Concentric Lesions with Concurrent Features of Schilder's
    Article / Autopsy Case Report Balo’s concentric lesions with concurrent features of Schilder’s disease in relapsing multiple sclerosis: neuropathological findings Maher Kurdia,b, David Ramsaya Kurdi M, Ramsay D. Balo’s concentric lesions with concurrent features of Schilder’s disease in relapsing multiple sclerosis: neuropathological findings. Autopsy Case Rep [Internet]. 2016;6(4):21-26. http://dx.doi.org/10.4322/acr.2016.058 ABSTRACT Atypical inflammatory demyelinating syndromes are rare neurological diseases that differ from multiple sclerosis (MS), owing to unusual clinicoradiological and pathological findings, and poor responses to treatment. The distinction between them and the criteria for their diagnoses are poorly defined due to the lack of advanced research studies. Balo’s concentric sclerosis (BCS) and Schilder’s disease (SD) are two of these syndromes and can present as monophasic or in association with chronic MS. Both variants are difficult to distinguish when they present in acute stages. We describe an autopsy case of middle-aged female with a chronic history of MS newly relapsed with atypical demyelinating lesions, which showed concurrent features of BCS and SD. We also describe the neuropathological findings, and discuss the overlapping features between these two variants. Keywords Multiple Sclerosis; Atypical Inflammatory Demyelination; Balo’s Concentric Sclerosis; Schilder’s Disease; Pathology CASE REPORT A 45-year-old woman presented in another treatment. Brain magnetic resonance imaging (MRI) hospital with a history of generalized tonic clonic with gadolinium contrast showed space-occupying seizure and acute confusion. She was admitted to lesions in the right and left frontal white matter, with the intensive care unit for close observation.
    [Show full text]
  • Para-Infectious and Post-Vaccinal Encephalomyelitis
    Postgrad Med J: first published as 10.1136/pgmj.45.524.392 on 1 June 1969. Downloaded from Postgrad. med. J. (June 1969) 45, 392-400. Para-infectious and post-vaccinal encephalomyelitis P. B. CROFT The Tottenham Group ofHospitals, London, N.15 Summary of neurological disorders following vaccinations of The incidence of encephalomyelitis in association all kinds (de Vries, 1960). with acute specific fevers and prophylactic inocula- The incidence of para-infectious and post-vaccinal tions is discussed. Available statistics are inaccurate, encephalomyelitis in Great Britain is difficult to but these conditions are of considerable importance estimate. It is certain that many cases are not -it is likely that there are about 400 cases ofmeasles notified to the Registrar General, whose published encephalitis in England and Wales in an epidemic figures must be an underestimate. In addition there year. is a lack of precise diagnostic criteria and this aspect The pathology of these neurological complications will be considered later. In the years 1964-66 the is discussed and emphasis placed on the distinction mean number of deaths registered annually in between typical perivenous demyelinating encepha- England and Wales as due to acute infectious litis, and the toxic type of encephalopathy which encephalitis was ninety-seven (Registrar General, occurs mainly in young children. 1967). During the same period the mean annual The clinical syndromes occurring in association number of deaths registered as due to the late effects with measles, chickenpox and German measles are of acute infectious encephalitis was seventy-four- considered. Although encephalitis is the most fre- this presumably includes patients with post-encepha-copyright.
    [Show full text]
  • Seizures in Encephalitis
    Neurology Asia 2008; 13 : 1 – 13 REVIEW ARTICLES Seizures in encephalitis Usha Kant Misra DM, *C T Tan MD, Jayantee Kalita DM Department of Neurology, Sanjay Gandhi PGIMS, Lucknow, India; *Department of Medicine, University of Malaya, Kuala Lumpur, Malaysia Abstract A large number of viruses can result in encephalitis. However, certain viruses are more prevalent in certain geographical regions. For example, Japanese encephalitis (JE) and dengue in South East Asia and West Nile in Middle East whereas Herpes simplex encephalitis (HSE) occurs all over the world without any seasonal or regional variation. Encephalitis can result in acute symptomatic seizures and remote symptomatic epilepsy. Risk of seizures after 20 years is 22% following encephalitis and 3% after meningitis with early seizures. Amongst the viruses, HSE is associated with most frequent and severe epilepsy. Seizures may be presenting feature in 50% because of involvement of highly epileptogenic frontotemporal cortex. Presence of seizures in HSE is associated with poor prognosis. HSE can also result in chronic and relapsing form of encephalitis and may be an aetiology factor in drug resistant epilepsy. Amongst the Flaviviruses, Japanese encephalitis is the most common and is associated with seizures especially in children. The frequency of seizures in JE is reported to be 6.9% to 46%. Associated neurocysticercosis in JE patients may aggravate the frequency and severity of seizures. Other flaviviruses such as equine, St Louis, and West Nile encephalitis can also produce seizures. In Nipah encephalitis, seizures are commoner in relapsed and late-onset encephalitis as compared to acute encephalitis (50% vs 24%). Other viruses like measles, varicella, mumps, influenza and enteroviruses may result in encephalitis and seizures.
    [Show full text]
  • Post-COVID-19 Acute Disseminated Encephalomyelitis in a 17-Month-Old
    Prepublication Release Post-COVID-19 Acute Disseminated Encephalomyelitis in a 17-Month-Old Loren A. McLendon, MD, Chethan K. Rao, DO, MS, Cintia Carla Da Hora, MD, Florinda Islamovic, MD, Fernando N. Galan, MD DOI: 10.1542/peds.2020-049678 Journal: Pediatrics Article Type: Case Report Citation: McLendon LA, Rao CK, Da Hora CC, Islamovic F, Galan FN. Post-COVID-19 acute disseminated encephalomyelitis in a 17-month-old. Pediatrics. 2021; doi: 10.1542/peds.2020- 049678 This is a prepublication version of an article that has undergone peer review and been accepted for publication but is not the final version of record. This paper may be cited using the DOI and date of access. This paper may contain information that has errors in facts, figures, and statements, and will be corrected in the final published version. The journal is providing an early version of this article to expedite access to this information. The American Academy of Pediatrics, the editors, and authors are not responsible for inaccurate information and data described in this version. Downloaded from©202 www.aappublications.org/news1 American Academy by of guest Pediatrics on September 27, 2021 Prepublication Release Post-COVID-19 Acute Disseminated Encephalomyelitis in a 17-month-old a,b Loren A. McLendon, MD, a,b Chethan K. Rao, DO, MS, c Cintia Carla Da Hora, MD, c Florinda Islamovic, MD, b Fernando N. Galan, MD Affiliations: a Mayo Clinic College of Medical Science Florida, Division of Child and Adolescent Neurology, Jacksonville, Florida b Nemours Children Specialty Clinic, Division of Neurology, Jacksonville, Florida c University of Florida College of Medicine Jacksonville, Division of Pediatrics, Jacksonville, Florida Corresponding Author: Fernando N.
    [Show full text]
  • Progressive Multifocal Leukoencephalopathy and the Spectrum of JC Virus-​Related Disease
    REVIEWS Progressive multifocal leukoencephalopathy and the spectrum of JC virus- related disease Irene Cortese 1 ✉ , Daniel S. Reich 2 and Avindra Nath3 Abstract | Progressive multifocal leukoencephalopathy (PML) is a devastating CNS infection caused by JC virus (JCV), a polyomavirus that commonly establishes persistent, asymptomatic infection in the general population. Emerging evidence that PML can be ameliorated with novel immunotherapeutic approaches calls for reassessment of PML pathophysiology and clinical course. PML results from JCV reactivation in the setting of impaired cellular immunity, and no antiviral therapies are available, so survival depends on reversal of the underlying immunosuppression. Antiretroviral therapies greatly reduce the risk of HIV-related PML, but many modern treatments for cancers, organ transplantation and chronic inflammatory disease cause immunosuppression that can be difficult to reverse. These treatments — most notably natalizumab for multiple sclerosis — have led to a surge of iatrogenic PML. The spectrum of presentations of JCV- related disease has evolved over time and may challenge current diagnostic criteria. Immunotherapeutic interventions, such as use of checkpoint inhibitors and adoptive T cell transfer, have shown promise but caution is needed in the management of immune reconstitution inflammatory syndrome, an exuberant immune response that can contribute to morbidity and death. Many people who survive PML are left with neurological sequelae and some with persistent, low-level viral replication in the CNS. As the number of people who survive PML increases, this lack of viral clearance could create challenges in the subsequent management of some underlying diseases. Progressive multifocal leukoencephalopathy (PML) is for multiple sclerosis. Taken together, HIV, lymphopro- a rare, debilitating and often fatal disease of the CNS liferative disease and multiple sclerosis account for the caused by JC virus (JCV).
    [Show full text]
  • Encephalitis Fact Sheet
    Encephalitis Fact Sheet What is encephalitis? Encephalitis is an inflammation (irritation and swelling) of the brain tissue. It can occur as a primary illness or as a result of another illness elsewhere in the body. Frequently caused by an infection with a virus, encephalitis can be mild or severe, but severe cases are rare. Who gets encephalitis? Anyone can get encephalitis, but young children, older adults, and persons with weakened immune systems are more at risk. How is encephalitis spread? Primary encephalitis occurs when a virus directly infects the brain. Viruses that are carried by infected mosquitoes and ticks can cause primary encephalitis. Other viruses can cause an illness and then encephalitis can develop as a complication of the viral illness. When encephalitis develops after another infection, it is called post-infectious encephalitis. Post-infectious encephalitis most commonly follows a bout of chickenpox, mumps, or measles. What are the symptoms of encephalitis? Encephalitis frequently causes headache, fever, confused thinking, seizures, or problems with vision, speech, or movement. Infants and young children might have nausea, vomiting, body stiffness, constant crying, and poor feeding. How soon after exposure do symptoms appear? Encephalitis can occur within two to three weeks after a viral illness. Symptoms begin within a few days to one or two weeks after the bite from an infected mosquito. How is encephalitis diagnosed? Medical evaluation and special tests are needed to confirm the diagnosis. Anyone with a severe headache, fever, and altered mental status should seek medical care immediately. What is the treatment for encephalitis? Doctors might prescribe antiviral drugs, anti-inflammatory drugs, or other treatments for the symptoms as needed.
    [Show full text]
  • Meningitis/Encephalitis Pathogen Panel
    Meningitis/Encephalitis Pathogen Panel The list of pathogens which can potentially cause meningitis, encephalitis, and meningoencephalitis is broad. Early effective therapy for both bacterial and certain viral pathogens has been associated with improved outcomes. Patients whose history, exam, and/or imaging suggests one of these conditions should have a lumber puncture performed with appropriate diagnostic testing including a cell count with differential, protein, and glucose. Additional tests to consider include bacterial culture, cryptococcal antigen testing, fungal cultures, cultures for acid fast bacilli and/or the new Meningitis/Encephalitis Pathogen Panel. Nebraska Medicine has recently introduced a new FDA-approved test called the Meningitis/Encephalitis Pathogen Panel (MEPP). This test uses a nested multiplex PCR-approach to amplify DNA targets directly from cerebrospinal fluid (CSF) in patients with signs and symptoms of meningitis or encephalitis. It is able to detect a variety of common bacterial, viral, and fungal pathogens (Table 1). Table 1: Pathogens Detected by Meningitis/Encephalitis Pathogen Panel Bacteria Viruses Yeast Gram-negative Cytomegalovirus Cryptococcus Escherichia coli K1 Enterovirus neoformans/gattii Haemophilus influenzae Herpes simplex virus 1 Neisseria meningitidis Herpes simplex virus 2 Gram-positive Human herpesvirus 6 Listeria monocytogenes Human parechovirus Streptococcus agalactiae (Group B Strep) Varicella zoster virus (VZV) Streptococcus pneumoniae This test is sensitive and very specific (see Supplementary Table 1 for complete detail), and should only be performed in patients where CNS infection is being seriously considered. Previous studies have shown that using clinical and CSF criteria to determine when to perform PCR testing is unlikely to miss clinically significant results and is highly cost-effective.1-3 For example Wilen, et al.3 restricted herpes virus and enterovirus PCR testing to patients who were: age <2 years, immunosuppressed, or who had >10 WBCs/µl.
    [Show full text]
  • Update on Viral Infections Involving the Central Nervous System in Pediatric Patients
    children Review Update on Viral Infections Involving the Central Nervous System in Pediatric Patients Giovanni Autore 1, Luca Bernardi 1, Serafina Perrone 2 and Susanna Esposito 1,* 1 Pediatric Clinic, Pietro Barilla Children’s Hospital, Department of Medicine and Surgery, University of Parma, Via Gramsci 14, 43126 Parma, Italy; [email protected] (G.A.); [email protected] (L.B.) 2 Neonatology Unit, Pietro Barilla Children’s Hospital, Department of Medicine and Surgery, University of Parma, Via Gramsci 14, 43126 Parma, Italy; serafi[email protected] * Correspondence: [email protected]; Tel.: +39-0521-704790 Abstract: Infections of the central nervous system (CNS) are mainly caused by viruses, and these infections can be life-threatening in pediatric patients. Although the prognosis of CNS infections is often favorable, mortality and long-term sequelae can occur. The aims of this narrative review were to describe the specific microbiological and clinical features of the most frequent pathogens and to provide an update on the diagnostic approaches and treatment strategies for viral CNS infections in children. A literature analysis showed that the most common pathogens worldwide are enteroviruses, arboviruses, parechoviruses, and herpesviruses, with variable prevalence rates in different countries. Lumbar puncture (LP) should be performed as soon as possible when CNS infection is suspected, and cerebrospinal fluid (CSF) samples should always be sent for polymerase chain reaction (PCR) analysis. Due to the lack of specific therapies, the management of viral CNS infections is mainly based on supportive care, and empiric treatment against herpes simplex virus (HSV) infection should be started as soon as possible.
    [Show full text]
  • Granulomatous Meningoencephalitis and Necrotizing Encephalitis
    Granulomatous Meningoencephalitis and Necrotizing Encephalitis A. Courtenay Freeman, DVM Marc Kent, DVM, DACVIM (Small Animal and Neurology) Scott J. Schatzberg, DVM, PhD, DACVIM (Neurology) BASIC INFORMATION TREATMENT AND FOLLOW-UP Description Granulomatous meningoencephalitis (GME) and necrotizing Treatment Options encephalitis (NE) are disorders that arise from inflammation of the Because GME and NE are caused by inflammation, treatment is brain and/or spinal cord and their coverings (the meninges). These initially directed at suppressing the inflammation with steroids. diseases affect predominantly young, small-breed dogs. High doses are used initially; as the animal improves, the dosage Causes may be lowered gradually over the course of months. The goal Both GME and NE are presently considered to be autoimmune dis- of therapy is to reduce the dosage to the minimal amount needed orders, meaning that the body launches an abnormal attack against to control the clinical signs. Side effects of steroids include its own nervous system tissues. Potential triggers for the autoim- increased thirst, appetite, and urination. Animals may breathe mune attack may include infections and vaccinations. Genetics heavily and pant excessively. Long-term side effects include a may also play a role in the development of GME and NE. thin hair coat, poor wound healing, and muscle loss. Steroid ther- Although any breed of dog may be affected with GME, toy apy can also make the dog prone to infections of the skin and breeds are affected most often. Breeds commonly affected by NE urinary tract. Notify your veterinarian if any of these side effects include the pug, Maltese, Yorkshire terrier, Chihuahua, French occur.
    [Show full text]
  • Balo`'S Concentric Sclerosis: Still to Be Considered As a Variant of Multiple Sclerosis?
    Neurol Sci (2015) 36:2277–2280 DOI 10.1007/s10072-015-2297-8 BRIEF COMMUNICATION Balo`’s concentric sclerosis: still to be considered as a variant of multiple sclerosis? Anna M. Pietroboni1 • Andrea Arighi1 • Milena A. De Riz1 • Laura Ghezzi1 • Alberto Calvi1 • Sabrina Avignone2 • Elisa Scola2 • Daniela Galimberti1 • Fabio Triulzi2 • Elio Scarpini1 Received: 26 March 2015 / Accepted: 16 June 2015 / Published online: 25 June 2015 Ó Springer-Verlag Italia 2015 Abstract Balo`’s concentric sclerosis (BCS) is considered a presentation of BCS. Moreover, these case reports suggest that rare demyelinating disease and regarded as an aggressive BCS may neither be rapidly progressive nor fatal and may be variant of multiple sclerosis (MS). We describe three cases considered part of the MS spectrum. In line with this hypoth- (one male and two females) with neuroimaging features sug- esis, current treatments for MS were effective in our patients. gestive of BCS and heterogeneous symptoms, with benign long-term clinical course upon treatment with natalizumab and Keywords Balo`’s concentric sclerosis (BCS) Á Multiple fingolimod. Neurological examination, blood and cere- sclerosis (MS) Á Clinically isolated syndrome (CIS) brospinal fluid analyses, brain and spinal cord magnetic reso- nance imaging (MRI) and brain proton magnetic resonance spectroscopy were performed. At onset, patient #1 showed Introduction predominant cognitive impairment with consciousness distur- bances; patient #2 presented with left hemiparesis; patient #3 Balo`’s concentric sclerosis (BCS) is a rare demyelinating demonstrated hesitance in speech and in written word pro- disease and it is regarded as one of the atypical forms of duction, along with right central facial palsy.
    [Show full text]
  • ADEM) After Autologous Peripheral Blood Stem Cell Transplant for Non-Hodgkin’S Lymphoma
    Bone Marrow Transplantation, (1999) 24, 1351–1354 1999 Stockton Press All rights reserved 0268–3369/99 $15.00 http://www.stockton-press.co.uk/bmt Case report Acute disseminated encephalomyelitis (ADEM) after autologous peripheral blood stem cell transplant for non-Hodgkin’s lymphoma A Re and R Giachetti Department of Hematology, University of Parma, Italy Summary: High-dose chemotherapy followed by autologous periph- eral blood stem cell transplantation (PBSCT) is a thera- Acute disseminated encephalomyelitis (ADEM) is a peutic intervention performed with increasing frequency for demyelinating disorder of the central nervous system hematologic and solid malignancies.4 The widespread use with an acute clinical onset and a wide variability in of this procedure depends on its safety and easy feasibility. severity and outcome. It usually follows a viral infection Mild organ toxicities and low incidence of life-threatening or an immunization and is thought to be immuno- complications are usually reported. Neurologic events are mediated. We report a case of ADEM with a dramatic frequently mild and reversible and usually secondary to clinical onset in an autologous peripheral blood stem injury to other organ systems.5 cell transplant (PBSCT) recipient for non-Hodgkin’s We report a case of ADEM in an autologous PBSCT lymphoma who developed the neurologic syndrome 12 recipient with non-Hodgkin’s lymphoma (NHL) who days after PBSC reinfusion. This is the first report of developed the syndrome on day ϩ12 after PBSC ADEM in the setting of autologous PBSCT, a thera- reinfusion, without any recognizable etiology. To our peutic procedure performed with increasing frequency knowledge, this is the first report of ADEM developing in a wide variety of hematologic and solid malignancies.
    [Show full text]
  • Acute Disseminated Encephalomyelitis
    Hatharasinghe et al. HCA Healthcare Journal of Medicine (2020) 1:2 https://doi.org/10.36518/2689-0216.1038 Case Report Acute Disseminated Encephalomyelitis Ashan Hatharasinghe, DO,1 Hossein Akhondi, MD,1 Don Pepito, MD1 Author affiliations are listed at the end of this article. Abstract Correspondence to: Introduction Ashan Hatharasinghe, DO Acute Disseminated Encephalomyelitis (ADEM) is a rare autoimmune demyelinating disor- 2880 North Tenaya Way der of the central nervous system. Clinical manifestations include encephalopathy, motor Las Vegas, NV, 89128 deficits, ataxia, and meningeal signs. In most cases, ADEM is preceded by either vaccination (Ashan.Hatharasinghe@ or viral illness. Here, we present a case with neither of the two predisposing elements. HCAhealthcare.com) Discussion A 28-year-old Hispanic female presenting with substance use and suicidal ideation was placed on an involuntary psychiatric hold, started on olanzapine and scheduled for a psychi- atric facility transfer. The following day, she was noted to have neurological deficits when ambulating. Computed tomography of the brain showed a right frontal lesion. Magnetic resonance imaging of the brain was notable for multiple peripherally enhancing white mat- ter lesions. Multiple sclerosis and other etiologies were ruled out through supporting tests and lumbar puncture. ADEM was suspected, and the patient was treated with both a five- day course of intravenous methylprednisolone as well as immune globulins. She continued to have mild expressive aphasia after treatment; however, the majority of her symptoms improved. Conclusions Diagnosis of ADEM versus multiple sclerosis can be difficult given there are no current diag- nostic criteria for it in the adult population.
    [Show full text]